Opinionated, data-backed coverage across all asset classes
FormFactor's Q1 2026 results reveal a pivot toward advanced semiconductor testing. Monitor probe card demand and margin trends to gauge future growth cycles.

Satellogic adds three defense veterans to its sales team, signaling a pivot toward sovereign geospatial intelligence contracts. Watch for government wins next.

Bicara Therapeutics will report Q1 2026 results on May 11 at 8:30 a.m. ET. Investors are watching for updates on clinical trial progress and cash runway.